GUMDROP : A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer (GUH)

Created by Nancy Dawson on May 19, 2013
Description:The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation therapy (ADT) + TAK-700 versus ADT + bicalutamide.
Link:http://clinicaltrials.gov/ct2/show/NCT01809691
Site:Georgetown University Hospital
Principal Investigator:Dr. Nancy Dawson